Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRRA | SPRY | SAVA | ||
| Company | Sierra Oncology Inc | Ars Pharmaceuticals Inc | Cassava Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.98 | 13.34 | 31.36 | ||
| High | 55.17 | 14.04 | 31.40 | ||
| Low | 54.98 | 13.25 | 26.02 | ||
| Last | 54.99 | 14.00 | 26.48 | ||
| Change | +0.02 | +0.62 | -5.70 | ||
| % Change | +0.04% | +4.63% | -17.71% | ||
| Volume | 862,800 | 1,016,800 | 7,438,200 | ||
| 20-Day Average Volume | 396,690 | 1,308,800 | 1,941,525 | ||
| Previous Close | 54.97 | 13.38 | 32.18 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.91 | 14.93 | 26.61 | ||
| 20-Day Raw Stochastic | 62.96% | 18.00% | 28.77% | ||
| 20-Day Relative Strength | 77.35% | 46.52% | 48.96% | ||
| Weighted Alpha | +89.10 | +145.92 | -23.82 | ||
| Today's Opinion | 100% Buy | 56% Buy | 48% Buy | ||
| Previous Opinion | 100% Buy | 56% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 06/23/22 | -0.07% since 11/15/24 | -1.60% since 11/15/24 | ||
| Low | 54.65 on 06/24/22 | 13.01 on 11/21/24 | 25.72 on 11/20/24 | ||
| High | 55.19 on 06/24/22 | 14.37 on 11/18/24 | 33.98 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | +0.38% since 05/27/22 | -16.62% since 10/22/24 | -6.86% since 10/22/24 | ||
| Low | 54.58 on 05/31/22 | 13.01 on 11/21/24 | 23.45 on 11/05/24 | ||
| High | 55.19 on 06/24/22 | 18.51 on 11/11/24 | 33.98 on 11/21/24 | ||
| 3-Month | |||||
| %Chg | +69.83% since 03/30/22 | +9.29% since 08/22/24 | -11.26% since 08/22/24 | ||
| Low | 30.87 on 03/31/22 | 11.00 on 09/06/24 | 23.45 on 11/05/24 | ||
| High | 55.19 on 06/24/22 | 18.51 on 11/11/24 | 33.98 on 11/21/24 | ||
| 6-Month | |||||
| %Chg | +144.40% since 12/30/21 | +56.77% since 05/22/24 | +19.71% since 05/22/24 | ||
| Low | 14.91 on 01/24/22 | 7.55 on 06/25/24 | 8.79 on 06/28/24 | ||
| High | 55.19 on 06/24/22 | 18.51 on 11/11/24 | 42.20 on 08/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,342,801 | 1,360,590 | 1,273,953 | ||
| Shares Outstanding, K | 24,419 | 97,185 | 48,110 | ||
| Annual Sales | 0 | 30,000 | 0 | ||
| Annual Net Income | -94,660,000 | -54,370,000 | -97,220,000 | ||
| Last Quarter Sales | 0 | 2,070,000 | 0 | ||
| Last Quarter Net Income | -27,930,000 | -19,130,000 | -27,940,000 | ||
| 60-Month Beta | 0.01 | 0.90 | -0.59 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.33 on 05/06/22 | -0.20 on 11/13/24 | -0.58 on 11/07/24 | ||
| Latest Earnings Date | 08/04/22 | 11/13/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | 0.750 on 12/13/12 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||